Federal Circuit: Costs Incurred In Hatch-Waxman Litigation Are Deductible
WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel held that the U.S. Court of Federal Claims did not err when it held that a generic drugmaker could deduct...To view the full article, register now.
Already a subscriber? Click here to view full article